Improving lung cancer screening through patient engagement
The MyLungHealth Study Protocol: A Pragmatic Patient-Randomized Controlled Trial to Evaluate a Patient-Centered, Electronic Health Record-Integrated Intervention to Enhance Lung Cancer Screening in Primary Care
NA · University of Utah · NCT06338592
This study is testing a new online tool to see if it can help more patients get screened for lung cancer by making it easier for them to understand their options and connect with their doctors.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 42415 (estimated) |
| Ages | 50 Years to 79 Years |
| Sex | All |
| Sponsor | University of Utah (other) |
| Locations | 2 sites (New York, New York and 1 other locations) |
| Trial ID | NCT06338592 on ClinicalTrials.gov |
What this trial studies
This study investigates the MyLungHealth intervention, which aims to enhance early lung cancer screening rates by engaging patients through a dedicated portal. It is a multi-site pragmatic trial involving primary care clinics at the University of Utah Health and NYU Langone Health. The intervention focuses on improving the identification of eligible patients and facilitating informed decision-making regarding lung cancer screening. The effectiveness of MyLungHealth will be evaluated by comparing its combined use with a provider-focused decision support tool against the tool alone.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 50-79 with a history of smoking who have visited a participating primary care clinic in the past year.
Not a fit: Patients who have not used the patient portal in the past year or have a lung cancer diagnosis at the start of the study will not benefit from this intervention.
Why it matters
Potential benefit: If successful, this intervention could significantly increase lung cancer screening rates, leading to earlier detection and improved patient outcomes.
How similar studies have performed: Other studies have shown success with patient-centered interventions in improving screening rates, making this approach promising but not entirely novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria for both study 1 and study 2: * aged 50-79 * a history of smoking (e.g., current or former tobacco use) * seen in a study primary care clinic in the 12 months preceding the start of the trial Exclusion criteria for both study 1 and study 2: * \>0 but \< 10 pack-year smoking history or quit more than 15 years ago * No use of the patient portal at least once in the year preceding the start of the study * A lung cancer diagnosis at the start of the study * LDCT completed in the past 3 years * Another chest CT completed in the past year * Structured EHR data indicating LCS SDM was provided in the past 3 years * Exposed to the intervention during the pilot phase Inclusion criteria for study 1: * a 10-19 pack-year smoking history, an unknown pack-year history, unknown quit date for patients who quit smoking, or a 0 pack-year smoking history Inclusion criteria for study 2: * at least a 20 pack-year smoking history and are a current smoker or have quit within the last 15 years
Where this trial is running
New York, New York and 1 other locations
- NYU Langone Health — New York, New York, United States (RECRUITING)
- University of Utah Health — Salt Lake City, Utah, United States (RECRUITING)
Study contacts
- Principal investigator: Kensaku Kawamoto, MD, PhD, MHS — University of Utah
- Study coordinator: Kensaku Kawamoto, MD, PhD
- Email: kensaku.kawamoto@utah.edu
- Phone: 8015878076
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Lung Cancer, Lung Neoplasms/Diagnosis